Association of corticosteroid therapy with reduced acute kidney injury and lower NET markers in severe COVID-19: an observational study
Corticosteroid treatment in severe COVID-19 is associated with a lower incidence of AKI and reduced concentrations of NET markers in plasma.
Authors
- Femke de Vries (ORCID: https://orcid.org/0000-0002-4281-0779)
- Michael Hultström (ORCID: https://orcid.org/0000-0003-4675-1099)
- Miklós Lipcsey (ORCID: https://orcid.org/0000-0002-1976-4129)
- Sara Bülow‐Anderberg (ORCID: https://orcid.org/0000-0002-8769-7036)
- Gerry A. F. Nicolaes (ORCID: https://orcid.org/0000-0002-2482-0412)
- Joram Huckriede (ORCID: https://orcid.org/0009-0004-7577-0154)
- Robert Frithiof (ORCID: https://orcid.org/0000-0003-2278-7951)
- Anders Larsson
Institutions
- Uppsala University (SE)
- Uppsala University Hospital (SE)
- Science for Life Laboratory (SE)
- Maastricht University (NL)
Publication Details
- Journal
- Intensive Care Medicine Experimental
- Published
- 2024-09-28
- DOI
- https://doi.org/10.1186/s40635-024-00670-3
- Citations
- 3
- Primary Topic
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.72
Funders
- Hjärt-Lungfonden
- Vetenskapsrådet
- Uppsala Universitet
- Science for Life Laboratory
- Svensk Njurmedicinsk Förening